PFM Health Sciences’s Audentes Therapeutics, Inc BOLD Stock Holding History

PFM Health Sciences’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,232,873	Closed	-$73.8M	–	86
2019 Q4	$73.8M	Sell	1,232,873 -1,083,065	-47%	-$40.6M	3.51%	5
2019 Q3	$65.1M	Sell	2,315,938 -912,741	-28%	-$31.2M	1.92%	15
2019 Q2	$122M	Buy	3,228,679 +1,198,198	+59%	+$46M	2.32%	9
2019 Q1	$79.2M	Sell	2,030,481 -990,778	-33%	-$28.4M	1.75%	21
2018 Q4	$64.4M	Buy	3,021,259 +1,467,120	+94%	+$37.9M	1.71%	25
2018 Q3	$61.5M	Buy	1,554,139 +1,128,757	+265%	+$42.1M	0.9%	46
2018 Q2	$16.3M	Buy	+425,382	New	+$15.8M	0.25%	97

PFM Health Sciences's BOLD Position: Q1 2020 in Review

PFM Health Sciences sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 1,232,873 shares — an estimated $73.8M sold.

PFM Health Sciences first reported a position in BOLD in Q2 2018 and held it in 7 quarters. The position peaked at $122M in Q2 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

PFM Health Sciences reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
PFM Health Sciences sold 1,232,873 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $73.8M.
PFM Health Sciences first reported a position in Audentes Therapeutics, Inc in Q2 2018 and held it in 7 quarters.
PFM Health Sciences's Audentes Therapeutics, Inc position peaked at $122M in Q2 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on PFM Health Sciences's 13F filing for Q1 2020, filed 15 May 2020.